Another research team developed a polyethyleneimine–polylactic acid–lipoic acid (PPL) micelle to simultaneously deliver STAT3 siRNA and paclitaxel (PTX) into the breast cancer model [194]. This evidence concerns the gene STAT3 and breast cancer.